html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

MET - Renal cell carcinoma, papillary type 1

This test is available for the following conditions:

Conditions > Renal / Nephrological > Renal cell carcinoma
Conditions > Oncogenetics > Renal cell carcinoma

This product is also part of the following panels:

Comprehensive preconception carrier test panel¹
Hearing impairment panel (including GJB2)
Hereditary cancer panel
Mendelian inherited disorders panel with genome wide CNV analysis
panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
Short stature/skeletal dysplasia panel with genome wide CNV analysis

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method